Treatment of rheumatic diseases in children

Special considerations

Diana S. Milojevic, Norman Todd Ilowite

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The goals of treatment of rheumatic diseases in children are to control the disease process while ensuring normal nutrition, growth, and development. The choice of antirheumatic drugs is similar in children and adults, but the doses, treatment schedules, and susceptibility to toxicity can differ considerably. In addition to differences between adult and pediatric diseases themselves, it is important for the rheumatologist who treats children to be cognizant of the impact of nutritional, developmental, and growth issues and differential susceptibility to toxicity of various treatments.

Original languageEnglish (US)
Pages (from-to)461-482
Number of pages22
JournalRheumatic Disease Clinics of North America
Volume28
Issue number3
DOIs
StatePublished - Aug 2002

Fingerprint

Rheumatic Diseases
Antirheumatic Agents
Growth and Development
Appointments and Schedules
Therapeutics
Pediatrics
Growth

ASJC Scopus subject areas

  • Rheumatology

Cite this

Treatment of rheumatic diseases in children : Special considerations. / Milojevic, Diana S.; Ilowite, Norman Todd.

In: Rheumatic Disease Clinics of North America, Vol. 28, No. 3, 08.2002, p. 461-482.

Research output: Contribution to journalArticle

@article{151012c6fe9f4b74b035b5a0cc84be93,
title = "Treatment of rheumatic diseases in children: Special considerations",
abstract = "The goals of treatment of rheumatic diseases in children are to control the disease process while ensuring normal nutrition, growth, and development. The choice of antirheumatic drugs is similar in children and adults, but the doses, treatment schedules, and susceptibility to toxicity can differ considerably. In addition to differences between adult and pediatric diseases themselves, it is important for the rheumatologist who treats children to be cognizant of the impact of nutritional, developmental, and growth issues and differential susceptibility to toxicity of various treatments.",
author = "Milojevic, {Diana S.} and Ilowite, {Norman Todd}",
year = "2002",
month = "8",
doi = "10.1016/S0889-857X(02)00009-1",
language = "English (US)",
volume = "28",
pages = "461--482",
journal = "Rheumatic Disease Clinics of North America",
issn = "0889-857X",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Treatment of rheumatic diseases in children

T2 - Special considerations

AU - Milojevic, Diana S.

AU - Ilowite, Norman Todd

PY - 2002/8

Y1 - 2002/8

N2 - The goals of treatment of rheumatic diseases in children are to control the disease process while ensuring normal nutrition, growth, and development. The choice of antirheumatic drugs is similar in children and adults, but the doses, treatment schedules, and susceptibility to toxicity can differ considerably. In addition to differences between adult and pediatric diseases themselves, it is important for the rheumatologist who treats children to be cognizant of the impact of nutritional, developmental, and growth issues and differential susceptibility to toxicity of various treatments.

AB - The goals of treatment of rheumatic diseases in children are to control the disease process while ensuring normal nutrition, growth, and development. The choice of antirheumatic drugs is similar in children and adults, but the doses, treatment schedules, and susceptibility to toxicity can differ considerably. In addition to differences between adult and pediatric diseases themselves, it is important for the rheumatologist who treats children to be cognizant of the impact of nutritional, developmental, and growth issues and differential susceptibility to toxicity of various treatments.

UR - http://www.scopus.com/inward/record.url?scp=0036698237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036698237&partnerID=8YFLogxK

U2 - 10.1016/S0889-857X(02)00009-1

DO - 10.1016/S0889-857X(02)00009-1

M3 - Article

VL - 28

SP - 461

EP - 482

JO - Rheumatic Disease Clinics of North America

JF - Rheumatic Disease Clinics of North America

SN - 0889-857X

IS - 3

ER -